Back

Diagnosis first: assessing kidney function in cardiovascular rehabilitation patients

4 April 2025 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk mechanisms beyond the heart Cardiovascular Rehabilitation EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Elisa Alba Schmidt

Hochgebirgsklinik Davos, Davos Wolfgang (Switzerland)

5 More presentations in this session

Presentation thumbnail
Validation of life's simple 7 and life's essential 8 in a european cohort: the role of sleep in cardiovascular risk estimation
Doctor M. Pengo (Milan, IT)
Abstract Slides
Presentation thumbnail
Having nightmares does not mean you will die or develop CVD. A population-based, prospective study.
Ms K. Liu (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Exploring the role of vitamin D supplements in chronic kidney disease: a cross-sectional and prospective analysis
Doctor S. Xie (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Prognostic accuracy of GFR estimation formulas in heart failure: the RENAL-MECKI Study
Doctor E. Salvioni (Milan, IT)
Abstract Slides
Presentation thumbnail
Nasal vs. oral BREATHing WIn Strategies in healthy individuals during cardiorespiratory exercise testing (BreathWISE)
Doctor I. Mattavelli (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk mechanisms beyond the heart

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Renal function as a cornerstone for risk stratification in acute heart failure
thumbnail
Congress Presentation
Correlation between renal function level and ventricular remodeling, and mechanistic study of slc10a6-mediated ventricular remodeling after chronic kidney disease
thumbnail
Congress Presentation
Angina of the kidney and the heart: the presence and prognostic impact of albuminuria in light of modern guideline-directed medical therapy in heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources